33354 Federal Register / Vol. 65, No. 100 / Tuesday, May 23, 2000 / Notices

Drug Schedule

Ethylmorphone (9190) ....................... II

Hydrocodone (9193) ......................... II

Isomethadone (9226) ........................ II

Meperidine (9230) ............................. II

Methadone (9250) ............................. II

Methadone intermediate (9254) ........ II

Dextropropoxyphene, bulk (non-dosage forms) (9273).II

Morphine (9300) ................................ II

Levo-Alphacetylmethadol (9648) ...... II

Oxymorphone (9652) ........................ II

Fentanyl (9801) ................................. II

The firm plans to manufacture small

quantities of the listed controlled

substances to produce standards for

analytical laboratories.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Iostec, Inc. to

manufacture the listed controlled

substances is consistent with the public

interest at this time. DEA has

investigated the company on a regular

basis to ensure that its continued

registration is consistent with the public

interest. These investigations have

included inspection and testing of the

company’s physical security systems,

audits of the company’s records,

verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: May 12, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–12842 Filed 5–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By notice dated February 10, 2000,

and published in the Federal Register

on February 17, 2000, (65 FR 33),

Novartis Pharmaceutical Corporation,

59 Route 10, East Hanover, New Jersey

07926, made application by renewal to

the Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of methylphenidate

(1724), a basic class of controlled

substance listed in Schedule II.

The firm plans to manufacture

finished product for distribution to its

customers.

DEA has considered the factors in title

21, United States Code, section 823(a)

and determined that the registration of

Novartis Pharmaceutical Corporation to

manufacture methylphenidate is

consistent with the public interest at

this time. DEA has investigated Novartis

Pharmaceutical Corporation on a regular

basis to ensure that the company’s

continued registration is consistent with

the public interest. These investigations

have included inspection and testing of

the company’s physical security

systems, audits of the company’s

records, verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated: May 12, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–12841 Filed 5–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title

21 of the Code of Federal Regulations

(CFR), this is notice that on March 30,

2000, Radian International LLC, 14050

Summit Drive #121, P.O. Box 201088,

Austin, Texas 78720–1088, made

application by renewal to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

Cathinone (1235) .............................. I

Methcathinone (1237) ....................... I

N-Ethylamphetamine (1475) ............. I

N-N-Dimethylamphetamine (1480) ... I

Aminorex (1585) ................................ I

4-Methylaminorex (cis isomer)

(1590).

I

Methaqualone (2565) ........................ I

Drug Schedule

Alpha-Ethyltryptamine (7249) ............ I

Lysergic acid diethylamide (7315) .... I

Tetrahydrocannabinols (7370) .......... I

Mescaline (7381) ............................... I

3,4,5-Trimethoxyamphetamine

(7390).

I

4-Bromo-2,5-dimethoxyamphetamine

(7391).

I

4-Bromo-2,5-

dimethoxyphenethylamine (7392).

I

4-Methyl-2,5-dimethoxyamphetamine

(7395).

I

2,5-Dimethoxyamphetamine (7396) .. I

2,5-Dimethoxy-4-ethylamphetamine

(7399).

I

3,4-Methylenedioxyamphetamine

(7400).

I

5-Methoxy-3,4-

methylenedioxyamphetamine

(7401).

I

N-Hydroxy-3,4-

methylenedioxyamphetamine

(7402).

I

3,4-Methylenedioxy-Nethylamphetamine (7404).I

3,4-

Methylenedioxymethamphetamine

(7405).

I

4-Methoxyamphetamine (7411) ........ I

Bufotenine (7433) .............................. I

Diethyltryptamine (7434) ................... I

Dimethyltryptamine (7435) ................ I

Psilocybin (7437) ............................... I

Psilocyn (7438) ................................. I

Acetyldihydrocodeine (9051) ............. I

Benzylmorphine (9052) ..................... I

Codeine-N-oxide (9053) .................... I

Dihydromorphine (9145) ................... I

Heroin (9200) .................................... I

Morphine-N-oxide (9307) .................. I

Normorphine (9313) .......................... I

Pholcodine (9314) ............................. I

Acetylmethadol (9601) ...................... I

Allyprodine (9602) ............................. I

Alphacetylmethadol except LevoAlphacetylmethadol (9603).I

Alphameprodine (9604) ..................... I

Alphamethadol (9605) ....................... I

Betacetylmethadol (9607) ................. I

Betameprodine (9608) ...................... I

Betamethadol (9609) ......................... I

Betaprodine (9611) ........................... I

Hydromorphinol (9627) ..................... I

Noracymethadol (9633) ..................... I

Norlevorphanol (9634) ...................... I

Normethadone (9635) ....................... I

Trimeperidine (9646) ......................... I

Para-Fluorofentanyl (9812) ............... I

3-Methylfentanyl (9813) .................... I

Alpha-methylfentanyl (9814) ............. I

Acetyl-alpha-methylfentanyl (9815) ... I

Beta-hydroxyfentanyl (9830) ............. I

Beta-hydroxy-3-methyfentanyl (9831) I

Alpha-Methylthiofentanyl (9832) ....... I

3-Methylthiofentanyl (9833) ............... I

Thiofentanyl (9835) ........................... I

Amphetamine (1100) ......................... II

Methamphetamine (1105) ................. II

Phenmetrazine (1631) ....................... II

Methylphenidate (1724) .................... II

Amobarbital (2125) ............................ II

Pentobarbital (2270) .......................... II

Secobarbital (2315) ........................... II